Search
Citas y referencias (10)
Thermo Scientific™
Pipetas de transferencia de tubo estrecho Samco™, pipetas de transferencia Sedi-Pet de 1.2 ml, tubo corto, no estériles
Realice aplicaciones de bancos de sangre, como procedimientos de sedimentación, con esta pipeta que cuenta con un vástago flexible que se dobla hacia la muestra desde tubos estrechos o pequeños.
Have Questions?
Cambiar vista
| Número de catálogo | Volumen (métrico) | Esterilidad | Dispositivo de aspiración con perilla (métricos) | Tipo de empaquetado |
|---|---|---|---|---|
| 252 | 15 ml | No estéril | 8 ml | A granel 250/paq., 10 paq./caja, 2500/caja |
| 241 | 1.2 ml | No estéril | 0.9 ml | A granel 500/paq., 8 paq./caja, 4000/cajas |
| 241-20S | 1,3 mL | Estéril | 0,8 mL | 20/bolsa, 500/paq., 4000/caja |
| 242NL-1S | 4 ml | Estéril | 3 ml | En envase individual |
| 694NL | < 6,7/ml | No estéril | < 3,0/ml | 500/paq. |
| 241NL | 1,2 ml | No estéril | 0,8 ml | 500/paq. |
| 241NL-1S | 1,2 ml | Estéril | 0,8 ml | En envase individual |
| 242NL | 4,0 ml | No estéril | < 3,0/ml | 500/paq. |
| 242NL-20S | 4,0 ml | Estéril | < 3,0/ml | 20/bolsa |
| 251NL | < 4,6/ml | No estéril | < 3,3/ml | 500/paq. |
| 252NL | 15 ml | No estéril | < 11,6/ml | 500/paq. |
| 252NL-20S | 15 ml | Estéril | < 11,6/ml | 20/bolsa |
| 242 | 4 ml | No estéril | 3 ml | A granel 500/paq., 10 paq./caja, 5000/caja |
| 242-1S | 4 ml | Estéril | 3 ml | En envase individual |
| 242-20S | < 4,3/ml | Estéril | < 3,1/ml | 20/bolsa, 760/paquete, 6080/caja. |
| 251 | 4.6 ml | No estéril | 3.3 ml | A granel 500/paq., 10 paq./caja, 5000/caja |
| 251-1S | 4.6 ml | Estéril | 3.3 ml | En envase individual |
| 251-20S | < 4,5/ml | Estéril | < 3,3/ml | 20/bolsa, 500/paquete, 4000/caja. |
| 252-1S | 15 ml | Estéril | 8 ml | En envase individual |
| 252-20S | < 15,3/ml | Estéril | < 11,6/ml | 20/bolsa, 200/paquete, 2000/caja. |
| 694-1S | < 6,9/ml | Estéril | 3,2 ml | En envase individual |
| 241-1S | 1,3 mL | Estéril | 0,8 mL | En envase individual |
Número de catálogo 252
Precio (MXN)
-
Volumen (métrico):
15 ml
Esterilidad:
No estéril
Dispositivo de aspiración con perilla (métricos):
8 ml
Tipo de empaquetado:
A granel 250/paq., 10 paq./caja, 2500/caja
Elimine la necesidad de taponar, empaquetar y esterilizar en autoclave con las pipetas de transferencia de tubo estrecho Thermo Scientific™ Samco™. Estas pipetas de polietileno evitan la contaminación cruzada y se utilizan con tubos y recipientes estrechos con aberturas pequeñas. El diseño individual incorpora una perilla de pipeta integrada y un tubo flexible que se dobla hacia la muestra desde los tubos estrechos o pequeños.
- Fabricadas con polietileno no tóxico a prueba de rotura
- Las superficies de baja afinidad evitan la unión de proteínas en aplicaciones de investigación
- Se pueden congelar en nitrógeno líquido o sellar con calor para el almacenamiento.
Periodo de garantía limitado: Este producto está sujeto a todos los requisitos de la garantía y a las exclusiones establecidas por nuestros términos y condiciones de venta. El plazo de garantía comienza a partir de la fecha del envío del producto y finaliza tras noventa (90) días.
Especificaciones
Dispositivo de aspiración con perilla (métricos)8 ml
DescripciónPipetas de transferencia Sedi-Pet, tubo estrecho, perilla grande
Diámetro exterior (métrico)3mm
Gotas/ml19
GraduadoNo
Tipo de empaquetadoA granel 250/paq., 10 paq./caja, 2500/caja
Cantidad250/paquete 2500/caja
DesechablesSí
Longitud (métrico)15.5 cm
MaterialLDPE
EsterilidadNo estéril
TipoPipeta de transferencia de tubo estrecho
Volumen (métrico)15 ml
Unit SizeCase of 2500
Citations & References (10)
Citations & References
Abstract
Characterization of the SIM-A9 cell line as a model of activated microglia in the context of neuropathic pain.
Journal:PLoS One
PubMed ID:32287325
'Resident microglia of the central nervous system are being increasingly recognized as key players in diseases such as neuropathic pain. Biochemical and behavioral studies in neuropathic pain rodent models have documented compelling evidence of the critical role of ATP mediated-P2X4R-brain-derived neurotrophic factor (BDNF) signaling pathway in the initiation and maintenance
Expression of the neonatal Fc-receptor in placental-fetal endothelium and in cells of the placental immune system.
Journal:Placenta
PubMed ID:30955709
'Starting from the second trimester of pregnancy, passive immunity is provided to the human fetus by transplacental transfer of maternal IgG. IgG transfer depends on the neonatal Fc receptor, FcRn. While FcRn localization in the placental syncytiotrophoblast (STB) has been demonstrated unequivocally, FcRn expression in placental-fetal endothelial cells (pFECs), which
Sleep-restriction Inhibits Neurogenesis Through Decreasing the Infiltration of CD169
Journal:Neuroscience
PubMed ID:32081723
'Chronic sleep-restriction (SR) is shown to be correlated with neurodevelopmental disorders. However, the effects of SR during stroke recovery on neurorepair remain unclear. In this study, mice were subjected to 60?min of cerebral ischemia followed by reperfusion. The SR protocol was accomplished by depriving mice of sleep for 20?h/day for
CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons.
Journal:Neuron
PubMed ID:31422865
CRISPR/Cas9-based functional genomics have transformed our ability to elucidate mammalian cell biology. However, most previous CRISPR-based screens were conducted in cancer cell lines rather than healthy, differentiated cells. Here, we describe a CRISPR interference (CRISPRi)-based platform for genetic screens in human neurons derived from induced pluripotent stem cells (iPSCs). We
The WNT/ß-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro.
Journal:Sci Rep
PubMed ID:30886380
Upregulated Wnt/ß-catenin signaling is associated with increased cancer cell resistance and cancer cell-elicited immunosuppression. In non-neoplastic immune cells, upregulated Wnt/ß-catenin is, however, associated with either immunosuppression or immunostimulation. Therefore, it is difficult to predict the therapeutic impact inhibitors of Wnt/ß-catenin signaling will have when combined with cancer immunotherapy. Here, we